NDC 37662-1653

Glonoinum

Glonoinum

Glonoinum is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Nitroglycerin.

Product ID37662-1653_ea2975ae-687c-500b-e053-2a95a90a2e32
NDC37662-1653
Product TypeHuman Otc Drug
Proprietary NameGlonoinum
Generic NameGlonoinum
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2022-10-03
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameHahnemann Laboratories, INC.
Substance NameNITROGLYCERIN
Active Ingredient Strength1 [hp_M]/1
Pharm ClassesNitrate Vasodilator [EPC], Nitrates [CS], Vasodilation [PE]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 37662-1653-1

200 PELLET in 1 VIAL, GLASS (37662-1653-1)
Marketing Start Date2022-10-03
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Glonoinum" or generic name "Glonoinum"

NDCBrand NameGeneric Name
0220-2279GlonoinumNITROGLYCERIN
0220-2282GlonoinumNITROGLYCERIN
0220-2283GlonoinumNITROGLYCERIN
0220-2286GlonoinumNITROGLYCERIN
0220-2287GlonoinumNITROGLYCERIN
0220-2290GlonoinumNITROGLYCERIN
0220-2291GlonoinumNITROGLYCERIN
0220-2293GlonoinumNITROGLYCERIN
15631-0207GLONOINUMGLONOINUM
15631-0591GLONOINUMGLONOINUM
37662-1647GlonoinumGlonoinum
37662-1648GlonoinumGlonoinum
37662-1649GlonoinumGlonoinum
37662-1650GlonoinumGlonoinum
37662-1651GlonoinumGlonoinum
37662-1652GlonoinumGlonoinum
37662-1653GlonoinumGlonoinum
37662-1654GlonoinumGlonoinum
37662-1655GlonoinumGlonoinum
60512-6281GLONOINUMGLONOINUM
62106-5945GLONOINUMGlyceryl trinitrate
68428-407GlonoinumNITROGLYCERIN
71919-318GlonoinumNITROGLYCERIN

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.